A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
Clinical trial NCT06880549 · RECRUITING
Trial details
- NCT number
- NCT06880549
- Sponsor
- ModernaTX, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-25
- Primary completion
- 2027-08-03
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.